The Trump administration announced Friday that it is not moving forward with a Biden-era proposal that would have expanded ...

New evidence suggests that factors other than the percentage of weight loss should be considered when determining the success ...

Joe Biden had proposed a rule in late November after Trump won re-election that would have extended coverage of drugs meant ...

President Donald Trump's administration has decided not to cover expensive, high-demand obesity treatments under the ...

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in ...

New York’s reputation as a trailblazer for health equity is in danger. We must ensure equity in obesity treatment.

India is facing a major health crisis, with rising obesity rates across all age groups, leading to increased early mortality ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

STOCKHOLM, SE / ACCESS Newswire / April 2, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) - AlzeCure Pharma AB (publ) (FN ...

Gastric bypass is the most clinically and cost-effective form of interventional surgery for people living with severe obesity ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Tirzepatide offers a promising treatment for patients with obesity, chronic kidney disease, and heart failure, improving both ...